Privia Health Group, Inc. (PRVA) Tops Q4 EPS by 16c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Privia Health Group Inc (PRVA) PT Raised to $32 at Citi
February 27, 2025 4:33 PM ESTCiti analyst Daniel Grosslight raised the price target on Privia Health Group Inc (NASDAQ: PRVA) to $32.00 (from $26.00) while maintaining a Buy rating.
The analyst comments "PRVA reported solid 4Q results beating guidance/expectations across the board. Practice collections grew ~5% y/y, as... More
